Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr Reddys Laboratories informs about press release
Date: 12-05-2021Dr Reddys Laboratories has informed that it has enclosed a Press Release on ‘Dr. Reddy's Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to Covid-19 Treatment in India.’
The above information is a part of company’s filings submitted to BSE.